Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coumestrol is a naturally occurring phytoestrogen belonging to the class of coumestans, polycyclic aromatic compounds derived from pterocarpan oxidation[3][2]. It is found in various plants including alfalfa, clover, legumes, soybeans, green beans, miso, and fruits[3][2]. Coumestrol mimics estrogen by binding to estrogen receptors ERα and ERβ, with a notably higher affinity for ERβ[3][5]. Its estrogenic potency is 30–100 times greater than that of typical isoflavones, but much less than estradiol[3]. Coumestrol acts as a competitive agonist at estrogen receptors, regulating metabolic, bone, and neuroprotective functions, and it can be used as a substitute for hormone therapy in conditions like menopause[3][5]. Mechanistically, it also inhibits aromatase and 3α-hydroxysteroid dehydrogenase, affecting steroid hormone biosynthesis[3]. Additional activities include selective and competitive inhibition of monoamine oxidase A (MAO-A) and inhibition of amyloid-beta (Aβ) aggregation, potentially useful in treating depression and Alzheimer's disease[1]. Coumestrol reversibly inhibits casein kinase II (CK2) as an ATP-competitive inhibitor[6]. It shows estrogen-mimetic effects on metabolic regulation, reducing fat accumulation and promoting bone mineralization[5]. Its metabolic and neuroprotective effects are primarily mediated via ERβ agonism[5]. Coumestrol exhibits mutagenic and clastogenic properties at high concentrations[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on coumestrol.